Retraction: Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure (PLoS ONE (2012) 7 :1 (e30322) DOI: 10.1371/journal.pone.0030322);Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Ling, Qi ^a   Xu, Xiao ^a   Wei, Qiang ^a   Liu, Xiaoli ^b   Guo, Haijun ^a   Zhuang, Li ^a   Chen, Jiajia ^b   Xia, Qi ^b   Xie, Haiyang ^a   Wu, Jian ^a   Zheng, Shusen ^a   Li, Lanjuan ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGE; ARTICLE; ARTIFICIAL LIVER SUPPORT SYSTEM; BIOARTIFICIAL LIVER; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASES; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME; ACUTE PHASE RESPONSE; ARTIFICIAL LIVER; BIOLOGICAL MODEL; CLASSIFICATION; DISEASE COURSE; DOWN REGULATION; EMERGENCY HEALTH SERVICE; EVALUATION; HEPATITIS B; IMMUNOSUPPRESSIVE TREATMENT; INSTRUMENTATION; LIVER DISEASE; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SALVAGE THERAPY;

ACUTE-PHASE REACTION; ADULT; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MODELS, BIOLOGICAL; PROGNOSIS; RESEARCH DESIGN; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; TRIAGE;

EID: 84856141386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0220487     Document Type: Erratum

References (32)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: S158-168.
2. Liu J, Fan D, (2007) Hepatitis B in China. Lancet 369: 1582-1583.
3. Jia JD, Zhuang H, (2004) The overview of the seminar on chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 12: 698-699.
4. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. (2009) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3: 269-282.
5. Liu CL, Fan ST, Lo CM, Wei WI, Yong BH, et al. (2003) Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation 76: 1174-1179.
6. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY, et al. (2007) Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Transplant Proc 39: 1501-1504.
7. Mao W, Ye B, Lin S, Fu Y, Chen Y, et al. (2010) Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. Asaio J 56: 475-478.
8. Yu JW, Sun LJ, Zhao YH, Li SC, (2008) Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol 23: 1242-1249.
9. Cai QC, Jiang Y, Lv LZ, Hu HZ, Zhang XJ, et al. (2009) Operative timing of liver transplantation for patients with severe hepatitis. Hepatobiliary Pancreat Dis Int 8: 479-482.
10. Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, et al. (2006) Artificial liver support system in China: a review over the last 30 years. Ther Apher Dial 10: 160-167.
11. Chen YS, Wu ZW, He JQ, Yu J, Yang SG, et al. (2007) The curative effect of ALSS on 1-month mortality in AoCLF patients after 72 to 120 hours. Int J Artif Organs 30: 906-14.
12. [Operating guide for artificial liver support system]. Zhonghua Gan Zang Bing Za Zhi 2002;10: 329-332.
13. Zheng S, Chen Y, Liang T, Lu A, Wang W, et al. (2006) Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl 12: 253-258.
14. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, et al. (2005) Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 37: 4359-4364.
15. Xu X, Ling Q, Zhang M, Gao F, He Z, et al. (2009) Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation 87: 1514-1519.
16. Wang WL, Zheng SS, Xu X, Liang TB, Jin J, et al. (2005) Clinical evaluation of emergency liver transplantation for patients with benign end-stage liver diseases. Zhonghua Yi Xue Za Zhi 85: 3460-3463.
17. Gao F, Xu X, Ling Q, Wu J, Zhou L, et al. (2009) Efficacy and safety of moderately steatotic donor liver in transplantation. Hepatobiliary Pancreat Dis Int 8: 29-33.
18. Wu J, Wang W, Zhang M, Shen Y, Liang T, et al. (2008) Reconstruction of middle hepatic vein in living donor liver transplantation with modified right lobe graft: a single center experience. Transpl Int 21: 843-849.
19. Yan S, Zhang QY, Yu YS, He JJ, Wang WL, et al. (2009) Microsurgical reconstruction of hepatic artery in living donor liver transplantation: experiences and lessons. Hepatobiliary Pancreat Dis Int 8: 575-580.
20. Xu X, Ling Q, He ZL, Gao F, Zheng SS, (2008) Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int 7: 465-470.
21. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470.
22. Xu X, Ling Q, Wu J, Chen J, Gao F, et al. (2007) A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Liver Int 27: 816-824.
23. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23: 164-176.
24. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR, (1998) Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 66: 302-310.
25. Xu X, Ling Q, Wei Q, Wu J, Gao F, et al. (2010) An effective model for predicting acute kidney injury after liver transplantation. Hepatobiliary Pancreat Dis Int 9: 259-263.
26. Shi-Chun L, Meng-Long W, Ning L, Wei L, Ping C, et al. (2010) Emergent right lobe adult-to-adult living-donor liver transplantation for high model for end-stage liver disease score severe hepatitis. Transpl Int 23: 23-30.
27. Liu Q, (2009) Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif 28: 331-341.
28. Pillay SP, Wynter C, Lynch S, Wall D, Balderson G, et al. (1997) Endotoxin levels in donors and recipients during orthotopic liver transplantation. Aust N Z J Surg 67: 187-191.
29. Kuramitsu K, Egawa H, Keeffe EB, Kasahara M, Ito T, et al. (2007) Impact of age older than 60 years in living donor liver transplantation. Transplantation 84: 166-172.
30. Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, et al. (2007) Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 13: 838-843.
31. Moreau R, Durand F, (2010) Renal insufficiency: Management prior to transplantation. Liver Transpl 16: S72-S76.
32. O'Riordan A, Donaldson N, Cairns H, Wendon J, O'Grady JG, et al. (2010) Risk score predicting decline in renal function postliver transplant: role in patient selection for combined liver kidney transplantation. Transplantation 89: 1378-1384.